Insider Transactions in Q4 2024 at Resmed Inc (RSMDF)
Insider Transaction List (Q4 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Nov 20
2024
|
Richard Sulpizio Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,083
+5.74%
|
-
|
Nov 20
2024
|
Desney Tan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,083
+18.01%
|
-
|
Nov 20
2024
|
Ronald R Taylor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,083
+4.37%
|
-
|
Nov 20
2024
|
Christopher Del Orefice Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,083
+44.51%
|
-
|
Nov 20
2024
|
Harjit Gill Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,083
+9.86%
|
-
|
Nov 20
2024
|
John Hernandez Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,083
+21.12%
|
-
|
Nov 20
2024
|
Jan De Witte Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,083
+12.18%
|
-
|
Nov 20
2024
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,083
+10.21%
|
-
|
Nov 20
2024
|
Carol Burt Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,083
+27.53%
|
-
|
Nov 20
2024
|
Peter C Farrell Director |
BUY
Grant, award, or other acquisition
|
Direct |
542
+0.65%
|
-
|
Nov 12
2024
|
Jan De Witte Director |
SELL
Open market or private sale
|
Direct |
796
-10.59%
|
$197,408
$248.81 P/Share
|
Nov 11
2024
|
Peter C Farrell Director |
SELL
Payment of exercise price or tax liability
|
Direct |
527
-0.63%
|
$132,804
$252.38 P/Share
|
Nov 11
2024
|
Harjit Gill Director |
SELL
Payment of exercise price or tax liability
|
Direct |
132
-1.47%
|
$33,264
$252.38 P/Share
|
Nov 11
2024
|
Michael J Rider Global General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,126
-2.78%
|
$283,752
$252.38 P/Share
|
Nov 11
2024
|
Michael J. Farrell Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,779
-0.63%
|
$2,212,308
$252.38 P/Share
|
Nov 11
2024
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Payment of exercise price or tax liability
|
Direct |
2,465
-7.17%
|
$621,180
$252.38 P/Share
|
Nov 08
2024
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.04%
|
$249,000
$249.0 P/Share
|
Nov 07
2024
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,683
-3.07%
|
$3,612,018
$246.26 P/Share
|
Nov 07
2024
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,683
+2.97%
|
$1,233,372
$84.98 P/Share
|
Nov 06
2024
|
Peter C Farrell Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.35%
|
$496,000
$248.74 P/Share
|
Nov 01
2024
|
Michael J Rider Global General Counsel |
SELL
Open market or private sale
|
Direct |
69
-0.66%
|
$16,698
$242.0 P/Share
|
Oct 30
2024
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
BUY
Other acquisition or disposition
|
Indirect |
9,628
+50.0%
|
-
|
Oct 30
2024
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Other acquisition or disposition
|
Direct |
9,628
-44.19%
|
-
|
Oct 11
2024
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
SELL
Open market or private sale
|
Direct |
4,260
-16.35%
|
$1,013,880
$238.48 P/Share
|
Oct 11
2024
|
Kaushik Ghoshal Chief Commercial Officer, SaaS |
BUY
Exercise of conversion of derivative security
|
Direct |
4,260
+14.06%
|
$430,260
$101.64 P/Share
|
Oct 08
2024
|
Brett Sandercock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,000
-1.03%
|
$233,000
$233.47 P/Share
|
Oct 07
2024
|
Michael J. Farrell Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,683
-3.07%
|
$3,391,773
$231.91 P/Share
|
Oct 07
2024
|
Michael J. Farrell Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,683
+2.98%
|
$1,233,372
$84.98 P/Share
|
Oct 02
2024
|
Peter C Farrell Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.29%
|
$474,000
$237.2 P/Share
|